Adaptation of Written Exposure Therapy in Substance Treatment

The purpose of this pilot non-randomized, uncontrolled clinical trial is to test the feasibility and efficacy of written exposure therapy (WET) for posttraumatic stress disorder (PTSD) as adapted for use within the context of residential substance use disorder (SUD) treatment. All participants meet criteria for PTSD and are in a short term residential SUD treatment program (target residential treatment duration = 28 days) regardless of the research. The main question the study aims to answer is: 1) Is the delivery of adapted WET feasible and acceptable in short term residential SUD treatment for individuals with severe SUD?

NCT Number	NCT07108608
Lead Sponsor	Potomac Health Foundations Collaborators: University of Maryland, Baltimore County
Conditions	Posttraumatic Stress Disorder, Substance Use Disorders
Enrollment	26 participants
Start Date	2025-11-21
Primary Completion	2026-06-22 (estimated)
Study Completion	2026-06-22 (estimated)
Updated on ClinicalTrials.gov	2026-06-29